Paper22697293
High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy.
Fraunholz I and 6 others. Radiat Oncol, 2012. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy. Papers, record 22697293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22697293
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anus Neoplasms | Major topic |
| Chemoradiotherapy | Major topic |
| Inhibitor of Apoptosis Proteins | Major topic |
| Antineoplastic Agents | |
| Female | |
| Fluorouracil | |
| Humans | |
| Immunohistochemistry | |
| Kaplan-Meier Estimate | |
| Male | |
| Middle Aged | |
| Mitomycin | |
| Neoplasm Staging | |
| Risk Factors | |
| Survivin |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20129247 | IAP regulation of metastasis. | Cancer Cell | 2010 | https://conductscience.org/library/papers/20129247 | PubMed |
| 2 | 15930309 | Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. | Cancer Res | 2005 | https://conductscience.org/library/papers/15930309 | PubMed |
| 3 | 12654446 | Spontaneous and radiation-induced apoptosis in colorectal carcinoma cells with different intrinsic radiosensitivities: survivin as a radioresistance factor. | Int J Radiat Oncol Biol Phys | 2003 | https://conductscience.org/library/papers/12654446 | PubMed |
| 4 | 11277325 | Immunohistochemical assessment of Ki-67 as prognostic cellular proliferation marker in anal canal carcinoma. | J Exp Clin Cancer Res | 2000 | https://conductscience.org/library/papers/11277325 | PubMed |
| 5 | 15326475 | Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms. | Oncogene | 2004 | https://conductscience.org/library/papers/15326475 | PubMed |
| 6 | 19259318 | Prognostic factors for squamous cell cancer of the anal canal. | Gastrointest Cancer Res | 2008 | https://conductscience.org/library/papers/19259318 | PubMed |
| 7 | 14695153 | Prognostic value of apoptosis-regulating protein expression in anal squamous cell carcinoma. | Clin Cancer Res | 2003 | https://conductscience.org/library/papers/14695153 | PubMed |
| 8 | 9579842 | Apparent lack of prognostic value of MIB-1 index in anal carcinomas treated by radiotherapy. | Br J Cancer | 1998 | https://conductscience.org/library/papers/9579842 | PubMed |
| 9 | 16740757 | Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma. | Clin Cancer Res | 2006 | https://conductscience.org/library/papers/16740757 | PubMed |
| 10 | 21041181 | Tumor survivin is downregulated by the antisense oligonucleotide LY2181308: a proof-of-concept, first-in-human dose study. | Clin Cancer Res | 2010 | https://conductscience.org/library/papers/21041181 | PubMed |
| 11 | 21110807 | The role of survivin for radiation oncology: moving beyond apoptosis inhibition. | Curr Med Chem | 2011 | https://conductscience.org/library/papers/21110807 | PubMed |
| 12 | 21118954 | Failure of downregulation of survivin following neoadjuvant radiochemotherapy in rectal cancer is associated with distant metastases and shortened survival. | Clin Cancer Res | 2011 | https://conductscience.org/library/papers/21118954 | PubMed |
| 13 | 20704571 | Survivin and IAP proteins in cell-death mechanisms. | Biochem J | 2010 | https://conductscience.org/library/papers/20704571 | PubMed |
| 14 | 18698017 | Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. | Clin Cancer Res | 2008 | https://conductscience.org/library/papers/18698017 | PubMed |
| 15 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 16 | 19559538 | Survivin: a new target for anti-cancer therapy. | Cancer Treat Rev | 2009 | https://conductscience.org/library/papers/19559538 | PubMed |
| 17 | 21264751 | Inhibitor of apoptosis protein family as diagnostic markers and therapeutic targets of colorectal cancer. | Surg Today | 2011 | https://conductscience.org/library/papers/21264751 | PubMed |
| 18 | 19399614 | Molecular biomarkers correlate with disease-free survival in patients with anal canal carcinoma treated with chemoradiation. | Dig Dis Sci | 2010 | https://conductscience.org/library/papers/19399614 | PubMed |
| 19 | 16919715 | Survivin protein expression and hypoxia in advanced cervical carcinoma of patients treated by radiotherapy. | Gynecol Oncol | 2007 | https://conductscience.org/library/papers/16919715 | PubMed |
| 20 | 19231102 | Survivin expression as a predictive marker for local control in patients with high-risk T1 bladder cancer treated with transurethral resection and radiochemotherapy. | Int J Radiat Oncol Biol Phys | 2009 | https://conductscience.org/library/papers/19231102 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39024554 | Transcriptome and microbiome-immune changes across preinvasive and invasive anal cancer lesions. | JCI Insight | 2024 | https://conductscience.org/library/papers/39024554 | PubMed |
| 29268708 | Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC. | BMC Cancer | 2017 | https://conductscience.org/library/papers/29268708 | PubMed |
| 29085358 | Peripheral Leukocytosis Is Inversely Correlated with Intratumoral CD8+ T-Cell Infiltration and Associated with Worse Outcome after Chemoradiotherapy in Anal Cancer. | Front Immunol | 2017 | https://conductscience.org/library/papers/29085358 | PubMed |
| 26845086 | Sequestering survivin to functionalized nanoparticles: a strategy to enhance apoptosis in cancer cells. | Biomater Sci | 2016 | https://conductscience.org/library/papers/26845086 | PubMed |
| 23494669 | Expression of survivin and its four splice variants in colorectal cancer and its clinical significances. | Med Oncol | 2013 | https://conductscience.org/library/papers/23494669 | PubMed |
| 23371446 | Anal cancer: are we making progress? | Curr Oncol Rep | 2013 | https://conductscience.org/library/papers/23371446 | PubMed |
| 23182495 | An oncolytic adenovirus regulated by a radiation-inducible promoter selectively mediates hSulf-1 gene expression and mutually reinforces antitumor activity of I131-metuximab in hepatocellular carcinoma. | Mol Oncol | 2013 | https://conductscience.org/library/papers/23182495 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BCL2 | 596 | PubTator's text mining | https://conductscience.org/library/genes/596 | NCBI Gene |
| BIRC5 | 332 | PubTator's text mining | https://conductscience.org/library/genes/332 | NCBI Gene |
| CCNA2 | 890 | PubTator's text mining | https://conductscience.org/library/genes/890 | NCBI Gene |
| CDKN1A | 1026 | PubTator's text mining | https://conductscience.org/library/genes/1026 | NCBI Gene |
| FN1 | 2335 | PubTator's text mining | https://conductscience.org/library/genes/2335 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| PTK2 | 5747 | PubTator's text mining | https://conductscience.org/library/genes/5747 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
| XIAP | 331 | PubTator's text mining | https://conductscience.org/library/genes/331 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22697293
GET https://conductscience.org/api/papers/v1/22697293/references?page=2